Spring House, PA – According to filings with the U.S. Securities and Exchange Commission, Halodine is raising $2,300,000.00 in new funding. Sources indicate as part of senior management Founder, Samuel Barone played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Halodine

Halodine is a proprietary povidone-iodine antiseptic developed by leading clinicians for repeated nasal and oral administration. Halodine Nasal Antiseptic and Halodine Oral Rinse have been proven effective against SARS-CoV-21, the virus causing COVID-19, as well as other infections. Safe and easy-to-use, Halodine is designed to help protect hospitalized patients, health care personnel, and consumers.

To learn more about Halodine, visit http://halodine.com/

Contact:
Samuel Barone, Founder
202-390-8590
https://www.linkedin.com/in/samuelbbarone/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved